Quarterly Result11 Nov 2025, 05:15 pm
JB Pharma Reports 8% Revenue Growth to INR 1085 Crores in Q2 FY26
AI Summary
JB Chemicals & Pharmaceuticals Ltd (JB Pharma) announced its financial results for the quarter ended 30th September 2025. The company recorded revenue of INR 1,085 crores, representing a growth of 8% from INR 1,001 crores in Q2 FY25. Operating EBITDA increased by 12% to INR 319 crores, and net profit rose by 19% to INR 208 crores.
Key Highlights
- Revenue growth of 8% to INR 1085 crores
- Operating EBITDA increased by 12% to INR 319 crores
- Net Profit increases by 19% to INR 208 crores
- Domestic business continued to outperform the market
- CDMO business grew by 20% to INR 113 crores